| Autor: |
Speed V; Department of Haematological Medicine, King's Thrombosis Centre, King's College Hospital, NHS Foundation Trust, London, United Kingdom.; Nuffield Department of Primary Care Health Sciences, Bennett Institute for Applied Data Science, University of Oxford, Oxford, United Kingdom., Clapham R; Department of Haematological Medicine, King's Thrombosis Centre, King's College Hospital, NHS Foundation Trust, London, United Kingdom., Bartoli-Abdou J; Department of Thrombosis and Haemostasis, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom., Stirling K; Department of Pharmacy, St. James's University Hospital, West Yorkshire, United Kingdom., Akor F; Department of Pharmacy, Imperial College Healthcare NHS Trust, London, United Kingdom., Collings V; Department of Thrombosis and Haemostasis, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom., Patel R; Department of Haematological Medicine, King's Thrombosis Centre, King's College Hospital, NHS Foundation Trust, London, United Kingdom., Byrne R; Department of Haematological Medicine, King's Thrombosis Centre, King's College Hospital, NHS Foundation Trust, London, United Kingdom., Arya R; Department of Haematological Medicine, King's Thrombosis Centre, King's College Hospital, NHS Foundation Trust, London, United Kingdom., Patel JP; Department of Haematological Medicine, King's Thrombosis Centre, King's College Hospital, NHS Foundation Trust, London, United Kingdom.; Institute of Pharmaceutical Science, King's College London, London, United Kingdom. |
| Abstrakt: |
Competing Interests: J.P.P., R.B., J.B.-A., R.C., F.A., and V.C. have no competing interests. V.S. and R.P. have received speaker fees from Bayer and K.S. has received speaker fees from Daiichi Sankyo. R.A. reports grants from Bayer; personal fees from Bayer, Medtronic, and Sanofi; and nonfinancial support from Bayer and Sanofi. |
